Notice Type
Departmental
Notice Title

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Bupafen epidural infusion
Active Ingredient(s): Bupivacaine hydrochloride (monohydrate) 1.319mg/mL equivalent to 1.25mg/mL bupivacaine hydrochloride anhydrous
Fentanyl citrate 3.144Ág/mL equivalent to 2.0 Ág/mL fentanyl
Dosage Form: Solution for infusion
New Zealand Sponsor: Biomed Limited
Manufacturer(s): Biomed Limited, Point Chevalier, Auckland
Product: DeWorm
Active Ingredient(s): Mebendazole 100mg
Dosage Form: Chewable tablet
New Zealand Sponsor: Multichem Laboratories Limited
Manufacturer(s): Cipla Limited, Manufacturing Division, Kurkumbh Village, Taluka - Daund, District - Pune (Maharashtra), India
Product: Invanz
Active Ingredient(s): Ertapenem sodium 209.2mg/mL equivalent to 200mg/mL ertapenem free acid
Dosage Form: Powder for injection
New Zealand Sponsor: Merck Sharp & Dohme (New Zealand) Limited
Manufacturer(s): Laboratoires Merck Sharp & Dohme - Chibret, (Mirabel Plant), Clermont-Ferrand, France
Product: Starlix
Active Ingredient(s): Nateglinide 120mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturer(s): Novartis Pharma Stein AG/SA, Stein, Switzerland
Product: Starlix
Active Ingredient(s): Nateglinide 180mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturer(s): Novartis Pharma Stein AG/SA, Stein, Switzerland
Product: Starlix
Active Ingredient(s): Nateglinide 60mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturer(s): Novartis Pharma Stein AG/SA, Stein, Switzerland
Product: Viratac
Active Ingredient(s): Aciclovir 5%w/w
Dosage Form: Topical cream
New Zealand Sponsor: Multichem Laboratories Limited
Manufacturer(s): Cipla Limited, Manufacturing Division, Patalganga, District Raigad, (Maharashtra), India

Dated this 16th day of October 2001.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).